Ireland's Department of Health is Requesting Comments Regarding Its National Biosimilars Medicines Policy

Published date21 August 2017
Law FirmGoodwin
Subject MatterConsultation,Biosimilars,Ireland,Department of Health and Human Services,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT